Welcome to CDC stacks | Resolution of Novel Human Papillomavirus–induced Warts after HPV Vaccination - 21526 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Resolution of Novel Human Papillomavirus–induced Warts after HPV Vaccination
  • Published Date:
    Jan 2014
  • Source:
    Emerg Infect Dis. 20(1):142-145.
Filetype[PDF-365.66 KB]


Details:
No Related Documents.
You May Also Like:
  1. Human papilloma virus vaccination and incidence of ocular surface squamous neoplasia
    Personal Author:
    Carroll, Joy N.; Willis, Zachary I.; de St Maurice, Annabelle; Kohanim, Sahar;
    Published:
    2017
    Source:
    Int Ophthalmol Clin. 57(1):57-74.
    File Type:
    Filetype[PDF - 103.07 KB]
  2. Human Papillomavirus Vaccination Coverage Among Adolescent Girls, 2007–2012, and Postlicensure Vaccine Safety Monitoring, 2006–2013 — United States
    Personal Author:
    Stokley, Shannon; Curtis, C. Robinette; Jeyarajah, Jenny; Harrington, Theresa; Gee, Julianne; Markowitz, Lauri;
    Published:
    Jul 26 2013
    Source:
    MMWR Morb Mortal Wkly Rep. 2013; 62(29):591-595.
    Description:
    Since mid-2006, the Advisory Committee on Immunization Practices (ACIP) has recommended routine vaccination of adolescent girls at ages 11 or 12 years with 3 doses of human papillomavirus (HPV) vaccine. Two HPV vaccines are currently available in the...
    File Type:
    Filetype[PDF - 206.36 KB]
  3. CDC Grand Rounds: Reducing the Burden of HPV-Associated Cancer and Disease
    Personal Author:
    Dunne, Eileen F.; Markowitz, Lauri E.; Saraiya, Mona; Stokley, Shannon; Middleman, Amy; Unger, Elizabeth R.; Williams, Alcia; Iskander, John;
    Published:
    Jan 31 2014
    Source:
    MMWR Morb Mortal Wkly Rep. 2014; 63(4):69-72.
    Description:
    Human papillomavirus (HPV) infection is the most common sexually transmitted infection in men and women in the United States. Most sexually active persons will acquire HPV in their lifetime. Recent data indicate that approximately 79 million persons ...
    File Type:
    Filetype[PDF - 241.90 KB]
  4. Model for Assessing Human Papillomavirus Vaccination Strategies
    Personal Author:
    Elbasha, Elamin H.; Dasbach, Erik J.; Insinga, Ralph P.;
    Published:
    Jan 2007
    Source:
    Emerg Infect Dis. 13(1):28-41.
    Description:
    We present a transmission dynamic model that can assess the epidemiologic consequences and cost-effectiveness of alternative strategies of administering a prophylactic quadrivalent (types 6/11/16/18) human papillomavirus (HPV) vaccine in a setting of...
    File Type:
    Filetype[PDF - 651.55 KB]
  5. Human Papillomavirus Vaccination Coverage Among Adolescents, 2007–2013, and Postlicensure Vaccine Safety Monitoring, 2006–2014 — United States
    Personal Author:
    Stokley, Shannon; Jeyarajah, Jenny; Yankey, David; Cano, Maria; Gee, Julianne; Roark, Jill; Curtis, C. Robinette; Markowitz, Lauri;
    Published:
    Jul 25 2014
    Source:
    MMWR Morb Mortal Wkly Rep. 2014; 63(29):620-624.
    Description:
    Since mid-2006, a licensed human papillomavirus (HPV) vaccine has been available and recommended by the Advisory Committee on Immunization Practices (ACIP) for routine vaccination of adolescent girls at ages 11 or 12 years. Two vaccines that protect ...
    File Type:
    Filetype[PDF - 226.37 KB]